FDA Listening Session
FDA Listening Session on Niemann-Pick Disease
NNPDF hosted an FDA listening session on Niemann-Pick Disease on Friday, April 9th, 2021. The listening session was a platform for the NNPDF to present to the FDA/CDER and to share the concerns and priorities from the entire Niemann-Pick Disease community.
The Listening Session Summary Report was submitted to the FDA along with several patient voice statements and the arimoclomol support letter which was signed by 500+ Niemann-Pick community members! Thank you for supporting your Niemann-Pick community!
To review the NNPDF FDA Listening Session Summary Report, please click here.